Activins and Cell Migration

Vitamins and Hormones

Volumn 85, Issue , 2011, Pages 129-148

  Kang, Hong Yo ^a   Shyr, Chih Rong ^b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Activins; Cancer metastasis and immune cells; Migration; Smads

Indexed keywords

ACTIVIN;

ANIMAL; BOOK; CELL MOTION; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ACTIVINS; ANIMALS; CELL MOVEMENT; HUMANS; SIGNAL TRANSDUCTION;

EID: 79951929590     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385961-7.00007-X     Document Type: Book

References (77)

1. Abe M., Shintani Y., Eto Y., Harada K., Kosaka M., Matsumoto T. Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells. J. Leukoc. Biol. 2002, 72:347-352.
2. Adkins H.B., Bianco C., Schiffer S.G., Rayhorn P., Zafari M., Cheung A.E., Orozco O., Olson D., De Luca A., Chen L.L., Miatkowski K., Benjamin C., et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J. Clin. Invest. 2003, 112:575-587.
3. Ball E.M., Risbridger G.P. Activins as regulators of branching morphogenesis. Dev. Biol. 2001, 238:1-12.
4. Bao Y.L., Tsuchida K., Liu B., Kurisaki A., Matsuzaki T., Sugino H. Synergistic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1/ERK2 MAPK signaling pathways. J. Endocrinol. 2005, 184:493-504.
5. Carey J.L., Sasur L.M., Kawakubo H., Gupta V., Christian B., Bailey P.M., Maheswaran S. Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth. Mol. Endocrinol. 2004, 18:696-707.
6. Castoria G., Lombardi M., Barone M.V., Bilancio A., Di Domenico M., Bottero D., Vitale F., Migliaccio A., Auricchio F. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell Biol. 2003, 161:547-556.
7. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
8. Cho S.H., Yao Z., Wang S.W., Alban R.F., Barbers R.G., French S.W., Oh C.K. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J. Immunol. 2003, 170:4045-4052.
9. Chuan Y.C., Pang S.T., Cedazo-Minguez A., Norstedt G., Pousette A., Flores-Morales A. Androgen induction of prostate cancer cell invasion is mediated by ezrin. J. Biol. Chem. 2006, 281:29938-29948.
10. Craft C.S., Romero D., Vary C.P., Bergan R.C. Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway. Oncogene 2007, 26:7240-7250.
11. de Guise C., Lacerte A., Rafiei S., Reynaud R., Roy M., Brue T., Lebrun J.J. Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner. Endocrinology 2006, 147:4351-4362.
12. de Kretser D.M., Meinhardt A., Meehan T., Phillips D.J., O'Bryan M.K., Loveland K.A. The roles of inhibin and related peptides in gonadal function. Mol. Cell. Endocrinol. 2000, 161:43-46.
13. Deacu E., Mori Y., Sato F., Yin J., Olaru A., Sterian A., Xu Y., Wang S., Schulmann K., Berki A., Kan T., Abraham J.M., et al. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. Cancer Res. 2004, 64:7690-7696.
14. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
15. Dolter K.E., Palyash J.C., Shao L.E., Yu J. Analysis of activin A gene expression in human bone marrow stromal cells. J. Cell. Biochem. 1998, 70:8-21.
16. Edlund S., Landstrom M., Heldin C.H., Aspenstrom P. Smad7 is required for TGF-beta-induced activation of the small GTPase Cdc42. J. Cell Sci. 2004, 117:1835-1847.
17. Ehata S., Hanyu A., Fujime M., Katsuno Y., Fukunaga E., Goto K., Ishikawa Y., Nomura K., Yokoo H., Shimizu T., Ogata E., Miyazono K., et al. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci. 2007, 98:127-133.
18. Eramaa M., Hurme M., Stenman U.H., Ritvos O. Activin A/erythroid differentiation factor is induced during human monocyte activation. J. Exp. Med. 1992, 176:1449-1452.
19. Funaba M., Ikeda T., Murakami M., Ogawa K., Abe M. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors. Cell. Signal. 2005, 17:121-128.
20. Funaba M., Ikeda T., Ogawa K., Abe M. Calcium-regulated expression of activin A in RBL-2H3 mast cells. Cell. Signal. 2003, 15:605-613.
21. Funaba M., Ikeda T., Ogawa K., Murakami M., Abe M. Role of activin A in murine mast cells: Modulation of cell growth, differentiation, and migration. J. Leukoc. Biol. 2003, 73:793-801.
22. Funaba M., Nakaya K., Ikeda T., Murakami M., Tsuchida K., Sugino H. Requirement of Smad3 for mast cell growth. Cell. Immunol. 2006, 240:47-52.
23. Giehl K., Imamichi Y., Menke A. Smad4-independent TGF-beta signaling in tumor cell migration. Cells Tissues Organs 2007, 185:123-130.
24. Graham H., Peng C. Activin receptor-like kinases: structure, function and clinical implications. Endocr. Metab. Immune Disord. Drug Targets 2006, 6:45-58.
25. Halder S.K., Beauchamp R.D., Datta P.K. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 2005, 7:509-521.
26. Harrison C.A., Wiater E., Gray P.C., Greenwald J., Choe S., Vale W. Modulation of activin and BMP signaling. Mol. Cell. Endocrinol. 2004, 225:19-24.
27. Hirota M., Watanabe K., Hamada S., Sun Y., Strizzi L., Mancino M., Nagaoka T., Gonzales M., Seno M., Bianco C., Salomon D.S. Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell. Signal. 2008, 20:1632-1641.
28. Hjelmeland M.D., Hjelmeland A.B., Sathornsumetee S., Reese E.D., Herbstreith M.H., Laping N.J., Friedman H.S., Bigner D.D., Wang X.F., Rich J.N. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol. Cancer Ther. 2004, 3:737-745.
29. Incorvaia L., Badalamenti G., Rini G., Arcara C., Fricano S., Sferrazza C., Di Trapani D., Gebbia N., Leto G. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res. 2007, 27:1519-1525.
30. Jacks T., Weinberg R.A. Taking the study of cancer cell survival to a new dimension. Cell 2002, 111:923-925.
31. Jaffe G.J., Roberts W.L., Wong H.L., Yurochko A.D., Cianciolo G.J. Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells. Exp. Eye Res. 1995, 60:533-543.
32. Jung B., Smith E.J., Doctolero R.T., Gervaz P., Alonso J.C., Miyai K., Keku T., Sandler R.S., Carethers J.M. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int. J. Cancer 2006, 118:2509-2513.
33. Jung B.H., Beck S.E., Cabral J., Chau E., Cabrera B.L., Fiorino A., Smith E.J., Bocanegra M., Carethers J.M. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology 2007, 132:633-644.
34. Kalkhoven E., Roelen B.A., de Winter J.P., Mummery C.L., van den Eijnden-van Raaij A.J., van der Saag P.T., van der Burg B. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ. 1995, 6:1151-1161.
35. Kang H.Y., Huang H.Y., Hsieh C.Y., Li C.F., Shyr C.R., Tsai M.Y., Chang C., Chuang Y.C., Huang K.E. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer. J. Bone Miner. Res. 2009, 24:1180-1193.
36. Kang H.Y., Huang K.E., Chang S.Y., Ma W.L., Lin W.J., Chang C. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J. Biol. Chem. 2002, 277:43749-43756.
37. Kang H.Y., Lin H.K., Hu Y.C., Yeh S., Huang K.E., Chang C. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc. Natl. Acad. Sci. USA 2001, 98:3018-3023.
38. Kang J.S., Liu C., Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol. 2009, 19:385-394.
39. Leto G., Incorvaia L., Badalamenti G., Tumminello F.M., Gebbia N., Flandina C., Crescimanno M., Rini G. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin. Exp. Metastasis 2006, 23:117-122.
40. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
41. Mathews L.S., Vale W.W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991, 65:973-982.
42. Mathews L.S., Vale W.W. Molecular and functional characterization of activin receptors. Receptor 1993, 3:173-181.
43. Mercado-Pimentel M.E., Runyan R.B. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 2007, 185:146-156.
44. Moustakas A., Heldin C.H. Dynamic control of TGF-beta signaling and its links to the cytoskeleton. FEBS Lett. 2008, 582:2051-2065.
45. Muenster U., Harrison C.A., Donaldson C., Vale W., Fischer W.H. An activin-A/C chimera exhibits activin and myostatin antagonistic properties. J. Biol. Chem. 2005, 280:36626-36632.
46. Murakami M., Ikeda T., Saito T., Ogawa K., Nishino Y., Nakaya K., Funaba M. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor. Cell. Signal. 2006, 18:256-265.
47. Musso T., Scutera S., Vermi W., Daniele R., Fornaro M., Castagnoli C., Alotto D., Ravanini M., Cambieri I., Salogni L., Elia A.R., Giovarelli M., et al. Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS ONE 2008, 3:e3271.
48. Nagakawa O., Akashi T., Hayakawa Y., Junicho A., Koizumi K., Fujiuchi Y., Furuya Y., Matsuda T., Fuse H., Saiki I. Differential expression of integrin subunits in DU-145/AR prostate cancer cells. Oncol. Rep. 2004, 12:837-841.
49. Oft M., Akhurst R.J., Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 2002, 4:487-494.
50. Ogino H., Yano S., Kakiuchi S., Muguruma H., Ikuta K., Hanibuchi M., Uehara H., Tsuchida K., Sugino H., Sone S. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin. Cancer Res. 2008, 14:660-667.
51. Ohguchi M., Yamato K., Ishihara Y., Koide M., Ueda N., Okahashi N., Noguchi T., Kizaki M., Ikeda Y., Sugino H., Nisihara T. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J. Interferon Cytokine Res. 1998, 18:491-498.
52. Okayama Y., Kawakami T. Development, migration, and survival of mast cells. Immunol. Res. 2006, 34:97-115.
53. Olsson N., Piek E., ten Dijke P., Nilsson G. Human mast cell migration in response to members of the transforming growth factor-beta family. J. Leukoc. Biol. 2000, 67:350-356.
54. Petraglia F., Sacerdote P., Cossarizza A., Angioni S., Genazzani A.D., Franceschi C., Muscettola M., Grasso G. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. J. Clin. Endocrinol. Metab. 1991, 72:496-502.
55. Plevova P., Krepelova A., Papezova M., Sedlakova E., Curik R., Foretova L., Navratilova M., Novotny J., Zapletalova J., Palas J., Nieslanik J., Horacek J., et al. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Neoplasma 2004, 51:275-284.
56. Razanajaona D., Joguet S., Ay A.S., Treilleux I., Goddard-Leon S., Bartholin L., Rimokh R. Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. Cancer Res. 2007, 67:7223-7229.
57. Ribeiro C., Petit V., Affolter M. Signaling systems, guided cell migration, and organogenesis: insights from genetic studies in Drosophila. Dev. Biol. 2003, 260:1-8.
58. Robertson D.M., Foulds L.M., Prisk M., Hedger M.P. Inhibin/activin beta-subunit monomer: isolation and characterization. Endocrinology 1992, 130:1680-1687.
59. Robson N.C., Phillips D.J., McAlpine T., Shin A., Svobodova S., Toy T., Pillay V., Kirkpatrick N., Zanker D., Wilson K., Helling I., Wei H., et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 2008, 111:2733-2743.
60. Saika S., Ikeda K., Yamanaka O., Sato M., Muragaki Y., Ohnishi Y., Ooshima A., Nakajima Y., Namikawa K., Kiyama H., Flanders K.C., Roberts A.B. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab. Invest. 2004, 84:1259-1270.
61. Salogni L., Musso T., Bosisio D., Mirolo M., Jala V.R., Haribabu B., Locati M., Sozzani S. Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood 2009, 113:5848-5856.
62. Scutera S., Riboldi E., Daniele R., Elia A.R., Fraone T., Castagnoli C., Giovarelli M., Musso T., Sozzani S. Production and function of activin A in human dendritic cells. Eur. Cytokine Netw. 2008, 19:60-68.
63. Stupack D.G., Cho S.Y., Klemke R.L. Molecular signaling mechanisms of cell migration and invasion. Immunol. Res. 2000, 21:83-88.
64. Swart G.W., Lunter P.C., Kilsdonk J.W., Kempen L.C. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?. Cancer Metastasis Rev. 2005, 24:223-236.
65. Talmadge J.E. Follistatin as an inhibitor of experimental metastasis. Clin. Cancer Res. 2008, 14:624-626.
66. Tsuchida K., Nakatani M., Hitachi K., Uezumi A., Sunada Y., Ageta H., Inokuchi K. Activin signaling as an emerging target for therapeutic interventions. Cell Commun. Signal. 2009, 7:15.
67. Valcourt U., Kowanetz M., Niimi H., Heldin C.H., Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 2005, 16:1987-2002.
68. Wu Y., Zhang X., Salmon M., Lin X., Zehner Z.E. TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim. Biophys. Acta 2007, 1773:427-439.
69. Xia Y., Schneyer A.L. The biology of activin: recent advances in structure, regulation and function. J. Endocrinol. 2009, 202:1-12.
70. Xu J., Lamouille S., Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
71. Yamashita N., Nakajima T., Takahashi H., Kaneoka H., Mizushima Y., Sakane T. Effects of activin A on IgE synthesis and cytokine production by human peripheral mononuclear cells. Clin. Exp. Immunol. 1993, 94:214-219.
72. Yoneyama H., Matsuno K., Matsushimaa K. Migration of dendritic cells. Int. J. Hematol. 2005, 81:204-207.
73. Yu E.W., Dolter K.E., Shao L.E., Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin. Exp. Immunol. 1998, 112:126-132.
74. Yu J., Shao L.E., Frigon N.L., Lofgren J., Schwall R. Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid. Immunology 1996, 88:368-374.
75. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
76. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004, 23:1155-1165.
77. Zhang L., Deng M., Parthasarathy R., Wang L., Mongan M., Molkentin J.D., Zheng Y., Xia Y. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol. Cell. Biol. 2005, 25:60-65.